Tissue Regenix Group (TRX) Insider Trading & Ownership → The asset beating inflation by 4x (From Colonial Metals) (Ad) Free TRX Stock Alerts GBX 61.50 0.00 (0.00%) (As of 05/3/2024 ET) Add Compare Share Share Insider TradesStock AnalysisChartCompetitorsInsider TradesStock AnalysisChartCompetitorsInsider Trades Tissue Regenix Group (LON:TRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage48.10%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)£3,657.42Number OfInsiders Selling(Last 12 Months)0 Get TRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Tissue Regenix Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TRX Insider Buying and Selling by Quarter Ad Awesomely, LLCAutomatic Income (from home)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free. Tissue Regenix Group Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/15/2023Brian PhillipsInsiderBuy6,773GBX 54£3,657.42 (Data available from 1/1/2013 forward) TRX Insider Trading Activity - Frequently Asked Questions Who is on Tissue Regenix Group's Insider Roster? The list of insiders at Tissue Regenix Group includes Brian Phillips, Daniel Lee, David Cocke, and Trevor Phillips. Learn more on insiders at TRX. What percentage of Tissue Regenix Group stock is owned by insiders? 48.10% of Tissue Regenix Group stock is owned by insiders. Learn more on TRX's insider holdings. Which Tissue Regenix Group insiders have been buying company stock? The following insiders have purchased TRX shares in the last 24 months: Brian Phillips (£3,657.42), and Daniel Lee (£5,000). How much insider buying is happening at Tissue Regenix Group? Insiders have purchased a total of 506,773 TRX shares in the last 24 months for a total of £8,657.42 bought. More Insider Trading Tools from MarketBeat Related Companies: e-therapeutics Insider Ownership OKYO Pharma Insider Ownership Poolbeg Pharma Insider Ownership Sareum Insider Ownership Oncimmune Insider Ownership OptiBiotix Health Insider Ownership Destiny Pharma Insider Ownership Oxford BioDynamics Insider Ownership Scancell Insider Ownership 4basebio Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (LON:TRX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchAutomatic Income (from home)Awesomely, LLCFW: 234x GainWeiss RatingsCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tissue Regenix Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
